🇺🇸 FDA
Patent

US 9567348

Substituted pyrazolo[1,5-a]pyrimidines as Syk inhibitors

granted A61KA61K9/0053A61P

Quick answer

US patent 9567348 (Substituted pyrazolo[1,5-a]pyrimidines as Syk inhibitors) held by GILEAD CONNECTICUT, INC. expires Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
GILEAD CONNECTICUT, INC.
Grant date
Tue Feb 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K9/0053, A61P, A61P1/00, A61P11/00